NCT05991687 Methods for Effective Disposal of Surplus Analgesics to Facilitate Elimination
| NCT ID | NCT05991687 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Michigan |
| Condition | Surgery |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2023-07-31 |
| Primary Completion | 2026-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2023-07-31 with a primary completion date of 2026-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary objective is to evaluate the difference in outcomes for mail-in vs. in-home disposal methods for leftover prescription opioids after discharge from surgery.
Eligibility Criteria
Inclusion Criteria: * Anticipated to be prescribed and use an opioid medication to treat acute pain after elective outpatient surgery * Opioid-naive Exclusion Criteria: * Inability to receive email and/or phone calls for follow up assessment
Contact & Investigator
Mark Bicket, MD, PhD
PRINCIPAL INVESTIGATOR
University of Michigan
Frequently Asked Questions
Who can join the NCT05991687 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Surgery. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05991687 currently recruiting?
Yes, NCT05991687 is actively recruiting participants. Contact the research team at hlipkovi@umich.edu for enrollment information.
Where is the NCT05991687 trial being conducted?
This trial is being conducted at Ann Arbor, United States.
Who is sponsoring the NCT05991687 clinical trial?
NCT05991687 is sponsored by University of Michigan. The principal investigator is Mark Bicket, MD, PhD at University of Michigan. The trial plans to enroll 100 participants.